e-learning
resources
Virtual 2020
Pre-Congress Content
Prognostic and predictive factors: treatment of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Type XIX collagen quantified in serum targeting the anti-tumorigenic NC1 domain is elevated in early and late stage lung carcinoma patients and COPD
D. Leeming (Herlev, Denmark), J. Thorlacius-Usssing (Herlev, Denmark), J. Sand (Herlev, Denmark), T. Manon-Jensen (Herlev, Denmark), S. Sun (Herlev, Denmark), M. Karsdal (Herlev, Denmark), N. Villumsen (Herlev, Denmark)
Source:
Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Session:
Prognostic and predictive factors: treatment of lung cancer
Session type:
E-poster session
Number:
1736
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Leeming (Herlev, Denmark), J. Thorlacius-Usssing (Herlev, Denmark), J. Sand (Herlev, Denmark), T. Manon-Jensen (Herlev, Denmark), S. Sun (Herlev, Denmark), M. Karsdal (Herlev, Denmark), N. Villumsen (Herlev, Denmark). Type XIX collagen quantified in serum targeting the anti-tumorigenic NC1 domain is elevated in early and late stage lung carcinoma patients and COPD. 1736
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
A neo-epitope of collagen type VII (C7) is elevated in serum of patients with COPD and SSC
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Serum type III procollagen peptide in idiopathic pulmonary fibrosis: peptide levels and anti-fibrosis therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005
The influence of roflumilast on the IV-type collagen level in patients with III stage COPD
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012
Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Type V collagen and endothelial apoptosis interface in non small cell lung cancer has impact on prognosis
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Microparticle-associated tissue factor activity is increased in late stage lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Late stage of experimental pulmonary fibrosis is modulated by collagen V
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
NSCLC stage IV
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
The role of cell lines in modelling the type II pneumocyte in interstitial lung disease
Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease
Year: 2020
Analysis of prognostic factors in patients with stage IIIB, IV non-small cell lung cancer
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
Collagen I, III and IV content in airways and lung parenchyma of COPD patients
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Validity of predictive estimate by physicians of the survival of patients with recently diagnosed stages IIIB and IV non-small cells lung cancer (NSCLC)
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Type I and III collagen protein precursors in the airways of smokers and COPD-patients
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Collagen degradation profile in serum of patients with COPD or IPF
Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Year: 2012
Stage IIIB and stage IV non-small cell lung cancers; responses to treatment and survival durations
Source: Eur Respir J 2004; 24: Suppl. 48, 302s
Year: 2004
MMP-2 expression in lung periphery is related to COPD progression
Source: Eur Respir J 2006; 28: Suppl. 50, 550s
Year: 2006
Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC)
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
The pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases
Source: ERJ Open Res, 4 (1) 00138-2016; 10.1183/23120541.00138-2016
Year: 2018
Analysis of survival and characteristics of patients with non-small cell lung carcinoma (NSCLC) stage IV depending on molecular markers
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept